OMER (OMER) Stock Price & Analysis
OMER (OMER) fell 0.84% to USD 18.95 as of September 8, 2026 at 07:34 UTC, according to Nexqual real-time market data.
OMER last closed at USD 18.95; the session ranged USD 18.9–19.23 on volume of 892,192 shares. Market capitalization is —, with a 52-week range of USD 3.94–19.65 (NGM). Source: Nexqual, September 8, 2026 at 07:34 UTC.
Key Statistics (as of September 8, 2026 at 07:34 UTC)
| Price | USD 18.95 |
|---|---|
| Change | ▼ 0.84% (down) |
| Previous Close | USD 18.95 |
| Open | USD 18.95 |
| Day Range | USD 18.9 – 19.23 |
| 52-Week Range | USD 3.94 – 19.65 |
| Volume | 892,192 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (OMER)
Nexqual's technical model rates OMER "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 07:34 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.25 (overbought) |
| vs SMA50 | Above (USD 13.5) |
| MACD | 1.63 (positive) |
From OMER's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OCUL | Ocular Therapeutix, Inc. | USD 10.64 | ▼ 2.39% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| VNDA | Vanda Pharmaceuticals Inc. | USD 5.43 | ▼ 1.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:34 UTC. This page is informational and not investment advice.